Remove 2000 Remove Collective Remove Patients Remove Safety
article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The public hearing attracted over 100 speakers and 2000 participants. The FDA is collecting data to fill these gaps. What’s Next?

CBD 80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why is US Cannabis Research Funded to Focus on Adverse Effects?

Veriheal

billion was funded into cannabis research between 2000 and 2018. Science Magazine goes on to explain that the database was put together by Jim Hudson, who collected the publicly available grant information from around 50 funders including the American NIH (National Institutes of Health). Scenario 1: Accuracy.

article thumbnail

Study: Oral CBD Use Has Anxiolytic and Anti-Psychotic Activity

The Joint Blog

For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. There is moderate-quality evidence that chronic and acute administration of CBD can improve psychotic symptoms in schizophrenia patients.”

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. The states’ situation varies substantially.

article thumbnail

The ‘Father of Cannabis Research’ Leaves a Lasting Legacy Aged 97

Veriheal

An Endless List of Achievements Spread Across Six Decades Professor Mechoulam’s career stretched over six decades, during which he threw himself into cannabis’ chemical makeup, determined to understand its safety and efficacy as a medicine. “I I have spent most of my life decoding the mysteries to be found within this incredible plant.

article thumbnail

What is the Nevada Dispensary Association?

Connor & Connor PLLC

Medical marijuana use was legalized in Nevada in 2000, but no mechanism for legal sales of marijuana existed at that time. This allowed for a bump in tax revenue the State would not have collected otherwise. Then, in 2013, Senator Tick Segerblom sponsored a bill that was later passed by the Nevada legislature.